718 reports of this reaction
6.2% of all LOTEPREDNOL ETABONATE reports
#1 most reported adverse reaction
EYE PAIN is the #1 most commonly reported adverse reaction for LOTEPREDNOL ETABONATE, manufactured by Bausch & Lomb Incorporated. There are 718 FDA adverse event reports linking LOTEPREDNOL ETABONATE to EYE PAIN. This represents approximately 6.2% of all 11,509 adverse event reports for this drug.
Patients taking LOTEPREDNOL ETABONATE who experience eye pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE PAIN is moderately reported among LOTEPREDNOL ETABONATE users, representing a notable but not dominant share of adverse events.
In addition to eye pain, the following adverse reactions have been reported for LOTEPREDNOL ETABONATE:
The following drugs have also been linked to eye pain in FDA adverse event reports:
EYE PAIN has been reported as an adverse event in 718 FDA reports for LOTEPREDNOL ETABONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE PAIN accounts for approximately 6.2% of all adverse event reports for LOTEPREDNOL ETABONATE, making it one of the most commonly reported side effect.
If you experience eye pain while taking LOTEPREDNOL ETABONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.